• Profile
Close

Reduced erythrocyte lifespan measured by chromium‐51 in patients with type 2 diabetes undergoing long‐term hemodialysis

Hemodialysis International Apr 05, 2021

Bomholt T, Oturai P, Rix M, et al. - Among patients with type 2 diabetes receiving long‐term hemodialysis, this inquiry was conducted to assess the erythrocyte lifespan as well as to identify potential predictors of erythrocyte lifespan. Participants were long‐term hemodialysis patients suffering from type 2 diabetes as well as patients with type 2 diabetes without nephropathy (estimated glomerular filtration rate > 60 mL/min/1.73 m 2 ). Findings revealed that patients suffering from type 2 diabetes receiving long‐term hemodialysis had a decreased erythrocyte lifespan. This may be a contributor to the decreased hemoglobin A1c values evident in the type 2 diabetic hemodialysis group. Experts could not identify a link between the erythrocyte lifespan and biochemical markers of hemolysis or inflammation.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay